Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
This study will determine whether quarterly injections of Ranibizumab may prevent eyes with
dry age-related macular degeneration from progressing to wet age-related macular degeneration
(AMD).